Overuse of short-acting ß<sub>2</sub>-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme.

Nwaru, Bright I; Ekström, Magnus; Hasvold, Pål; Wiklund, Fredrik; Telg, Gunilla; Janson, Christer

Overuse of short-acting ß₂-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme.

Nwaru, Bright I; Ekström, Magnus; Hasvold, Pål; Wiklund, Fredrik; Telg, Gunilla; Janson, Christer.

Nwaru BI; Krefting Research Centre, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden.
Ekström M; Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, Gothenburg, Sweden.
Hasvold P; Lund University, Faculty of Medicine, Dept of Clinical Sciences Lund, Respiratory Medicine and Allergology, Lund, Sweden.
Wiklund F; AstraZeneca Nordic-Baltic, Södertälje, Sweden.
Telg G; Statisticon AB, Uppsala, Sweden.
Janson C; AstraZeneca Nordic-Baltic, Södertälje, Sweden.

Eur Respir J ; 55(4)2020 04.

Article en En | MEDLINE | ID: mdl-31949111

Asunto(s)

Antiasmáticos; Asma; Administración por Inhalación; Corticoesteroides/uso terapéutico; Adulto; Antiasmáticos/efectos adversos; Asma/tratamiento farmacológico; Estudios de Cohortes; Femenino; Hospitalización; Humanos; Masculino; Suecia/epidemiología

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Asma / Antiasmáticos Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male País como asunto: Europa Idioma: En Año: 2020 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google